BRCA2 and pancreatic neoplasm: The mutation rates of BRCA1 and BRCA2 in familial pancreatic cancers are <1.2% and 5–17%, respectively, and those mutations increase the risk of disease by 2.26-fold and 3.5 to 10-fold.